`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
` SUPERCELL OY,
` Petitioner,
`
`v.
`
` GREE, INC.,
` Patent Owner.
`
`Case PGR2020-00088
`U.S. Patent No. 10,518,177
`
`PATENT OWNER’S SUR-REPLY TO PETITIONER’S REPLY TO
`PATENT OWNER’S PRELIMINARY RESPONSE
`
`
`
`TABLE OF CONTENTS
`
`Page
`The Petition Should Be Denied Under § 324(a) .............................................. 1
`The Petition Failed to Demonstrate that MH Was Publicly
`Accessible ........................................................................................................ 6
`
`I.
`II.
`
`i
`
`
`
`TABLE OF AUTHORITIES
`
`Page(s)
`
`Cases
`10X Genomics, Inc. v. President & Fellows of Harvard College,
`IPR2020-01180, Paper 23 (P.T.A.B. Jan. 13, 2021) ........................................1, 5
`Apple Inc. v. Seven Networks, LLC,
`IPR2020-00235, Paper 10 (P.T.A.B. July 28, 2020) ............................................ 5
`Celltrion, LLC v. Biogen, Inc.,
`IPR2017-01230, Paper 10 (P.T.A.B. Oct 12, 2017) ............................................. 7
`Google LLC v. IPA Techs. Inc.,
`IPR2018-00384, Paper 8 (P.T.A.B. July 3, 2018) ................................................ 7
`Guardian Alliance Techs., Inc. v. Miller,
`IPR2020-00031, Paper 27 (P.T.A.B. July 27, 2020) ............................................ 6
`Hulu, LLC v. Sound View Innovations, LLC,
`IPR2018-01039, Paper 29 (P.T.A.B. Dec. 20, 2019) ........................................... 6
`KeyMe, LLC v. The Hillman Group, Inc.,
`IPR2020-01028, Paper 12 (P.T.A.B. Jan. 13, 2021) ............................................ 2
`Oticon Medical AB v. Cochlear Limited,
`IPR2019-00975, Paper 15 (P.T.A.B. Oct. 16, 2019) ............................................ 4
`Samsung Elecs. Co. Ltd. v. Clear Imaging Research, LLC,
`IPR2020-01552, Paper 11 (P.T.A.B. Mar. 3, 2021) .................................... 2, 4, 5
`Sand Revolution II, LLC v. Cont’l Intermodal Group,
`IPR2019-01393, Paper 24 (P.T.A.B. June 16, 2020) ........................................... 3
`Snap, Inc. v. SRK Tech. LLC,
`IPR2020-00820, Paper 15 (P.T.A.B. Oct. 21, 2020) ............................................ 4
`Sotera Wireless, Inc. v. Masimo Corp.,
`IPR2020-01019, Paper 12 (P.T.A.B. Dec. 1, 2020) ............................................. 4
`
`ii
`
`
`
`Supercell Oy v. GREE, Inc.,
`IPR2020-00215, Paper 10 (P.T.A.B. June 10, 2020) ........................................... 5
`Supercell Oy v. GREE, Inc.,
`PGR2020-00039, Paper 14 (P.T.A.B. Sept. 14, 2020) ......................................... 3
`
`iii
`
`
`
`LIST OF EXHIBITS
`
`Exhibit No.
`2001
`
`Description
`Third Amended Docket Control Order, GREE, Inc. v. Supercell
`Oy, Civil Action No. 2:19-cv-00413, Document 98 (E.D. Tex.
`Dec. 30, 2020)
`
`2002
`
`2003
`
`2004
`
`2005
`
`2006
`
`2007
`
`2008
`
`2009
`
`2010
`
`Complaint, GREE, Inc. v. Supercell Oy, Civil Action No. 2:19-cv-
`00413, Document 1 (E.D. Tex. Dec. 31, 2019)
`
`Defendant Supercell Oy’s Preliminary Ineligibility Contentions,
`GREE, Inc. v. Supercell Oy, Civil Action No. 2:19-cv-00413 (E.D.
`Tex.), dated June 1, 2020
`
`Defendant Supercell Oy’s Invalidity Contentions and Disclosures
`Under Local Patent Rules 3-3 and 3-4, GREE, Inc. v. Supercell Oy,
`Civil Action No. 2:19-cv-00413 (E.D. Tex.), dated June 1, 2020
`
`Exhibit A-4 to Defendant Supercell Oy’s Invalidity Contentions
`and Disclosures Under Local Patent Rules 3-3 and 3-4, GREE, Inc.
`v. Supercell Oy, Civil Action No. 2:19-cv-00413 (E.D. Tex.),
`dated June 1, 2020
`
`Excerpts of the Expert Report of Stacy Friedman, GREE, Inc. v.
`Supercell Oy, Civil Action No. 2:19-cv-00413 (E.D. Tex.), dated
`December 23, 2020
`
`Buehler, Katie, ‘Clash of Clans’ Game Maker Owes $8.5M, Texas
`Jury Says, Law360 (September 18, 2020)
`
`Order, Solas OLED Ltd. v. Samsung Display Co., Ltd. et al., Civil
`Action No. 2:19-cv-001520, Document 302 (E.D. Tex. Nov. 20,
`2020)
`
`Claim Construction Memorandum Opinion and Order, GREE, Inc.
`v. Supercell Oy, Civil Action No. 2:19-cv-00413, Document 85
`(E.D. Tex. Nov. 6, 2020)
`
`Notice of Hearing, GREE, Inc. v. Supercell Oy, Civil Action No.
`2:19-cv-00413 (E.D. Tex. Jan. 7, 2021)
`iv
`
`
`
`Exhibit No.
`2011
`
`Description
`Fourth Amended Docket Control Order, GREE, Inc. v. Supercell
`Oy, Civil Action No. 2:19-cv-00413, Document 100 (E.D. Tex.
`Jan. 29, 2021)
`
`2012
`
`2013
`
`Joint Motion to Amend Docket Control Order, GREE, Inc. v.
`Supercell Oy, Civil Action No. 2:19-cv-00413, Document 137
`(E.D. Tex. Mar. 5, 2021)
`
`Second Amended Docket Control Order, GREE, Inc. v. Supercell
`Oy, Civil Action No. 2:20-cv-00113, Document 49 (E.D. Tex.
`Dec. 30, 2020)
`
`v
`
`
`
`I.
`
`The Petition Should Be Denied Under § 324(a)
`In Patent Owner’s Preliminary Response (Paper 7, “POPR”), Patent Owner
`
`explains why the Board should exercise its discretion under 35 U.S.C. § 324(a) to
`
`deny the instant Petition in accordance with a holistic review of all the Fintiv factors.
`
`In Reply, Petitioner boldly asks this Board to disregard a majority of the Fintiv
`
`factors and simply find “Factors 4 and 6 to be definitive.” Paper 8 (“Reply”), at 3.
`
`This is improper and incorrect. Moreover, Petitioner’s cursory dismissal of Fintiv
`
`Factors 1, 3, and 5 as “neutral” or of “little weight” is not only inappropriate, but
`
`also belied by the record. See POPR, at 8–10, 16–20, 31. And Petitioner’s arguments
`
`regarding Factors 4 and 6, as well as Factor 2, fail for similar and additional reasons.
`
`A.
`
`Fintiv Factor 2: Trial Date Remains Well in Advance of Board’s
`Statutory Deadline for Final Written Decision
`Petitioner’s speculative claim that trial in the parallel district court proceeding
`
`may not proceed in short order ignores that the district court’s continuance of other
`
`in-person jury trials “during December of 2020 and January through February of
`
`2021” does not expressly modify the jury trial in the parallel proceeding here. Ex.
`
`2008. Petitioner urges the Board to ignore this fact and, instead, speculate that the
`
`continuance will “cause a cascade of delays to the Court’s calendar.” Reply, at 4.
`
`But this Board “decline[s] … to speculate how long [a] trial date … may be delayed
`
`due to the effects of [a] district court’s backlog and practices in light of the COVID-
`
`19 pandemic.” 10X Genomics, Inc. v. President & Fellows of Harvard College,
`
`
`
`IPR2020-01180, Paper 23, at 11 (P.T.A.B. Jan. 13, 2021). And this Board has, in
`
`fact, rejected this same argument from another petitioner regarding this same
`
`continuance by the district court—in favor of facts in the record. KeyMe, LLC v. The
`
`Hillman Group, Inc., IPR2020-01028, Paper 12, at 8–9 (P.T.A.B. Jan. 13, 2021).
`
`Additionally, the parties filed a motion to reschedule the trial in the parallel
`
`proceeding from May 3, 2021 to August 2, 2021—when the parties are already
`
`calendared for a trial involving the same accused product (Ex. 2013, at 1)—to
`
`alleviate any stress on the district court’s calendar. Ex. 2012. But this slight delay
`
`does not “materially alter” the weighing of this factor given trial will still occur more
`
`than eight months before the deadline to issue a final written decision under this
`
`schedule. See, e.g., Samsung Elecs. Co. Ltd. v. Clear Imaging Research, LLC,
`
`IPR2020-01552, Paper 11, at 16 (P.T.A.B. Mar. 3, 2021) (“[E]ven if we were to
`
`assume that there may be a four-month delay, this factor would still weigh in favor
`
`of exercising our discretion to deny institution because the parallel trial in the District
`
`Court would begin about seven months before a Final Written Decision would be
`
`due in this proceeding.”); KeyMe, IPR2020-01028, Paper 12, at 8–9 (similar).
`
`Petitioner’s further speculation regarding the trial date due to alleged
`
`uncertainly as to “whether and when the Court will conduct any future trials” (Reply,
`
`at 4–5) similarly fails. See Ex. 2011, at 1. First, the district court has already resumed
`
`jury trials as of March 1, 2021. Second, the Board has recognized that any
`2
`
`
`
`“generalized speculation as to trial dates universally (e.g., due to impacts of COVID-
`
`19)” is “outweighed” by the fact that the jury trial in a parallel proceeding is
`
`scheduled to occur a significant number of months before the Board’s statutory
`
`deadline for a final written decision—as is the case here. See POPR, at 13–14.
`
`The facts here are distinguishable from those in Sand Revolution II, LLC v.
`
`Cont’l Intermodal Group, IPR2019-01393, Paper 24 (P.T.A.B. June 16, 2020).
`
`There, the court had entered a “loose date at which trial might occur,” which the
`
`Board found “indicates a continuing degree of recognized uncertainty of the court’s
`
`schedule by the court.” Id. at 9; Supercell Oy v. GREE, Inc., PGR2020-00039, Paper
`
`14, at 11 (P.T.A.B. Sept. 14, 2020). No such uncertainty exists here, as discussed.
`
`See Ex. 2012, at 2; see also Ex. 2011, at 1. Indeed, the parties are already calendared
`
`for a trial involving the same accused product on August 2, 2021. Ex. 2013, at 1.
`
`Fintiv Factor 4: Substantial Overlap of Issues in the Two Forums
`B.
`Petitioner does not dispute some overlap of issues between the two tribunals,
`
`including in view of Petitioner’s common assertion of the Gilson reference. See
`
`POPR, at 21–31. Petitioner argues simply that discretionary denial is inappropriate
`
`because a single reference cited in the Petition (Master Hearthstone, “MH”) is not
`
`also at issue in the litigation. Reply, at 1. But, as Patent Owner previously explained,
`
`this factor does not require complete duplication of prior art evidence between the
`
`3
`
`
`
`two forums. See POPR, at 29–30; Samsung, IPR2020-01552, Paper 11, at 24. And
`
`tellingly, Petitioner fails to acknowledge, let alone rebut, that argument.
`
`Instead, Petitioner relies on inapposite decisions. In Oticon Medical AB v.
`
`Cochlear Limited, the Board declined to exercise discretion under § 314(a) after “a
`
`balanced assessment of all relevant circumstances,” including the absence of a trial
`
`date. IPR2019-00975, Paper 15, at 22–24 (P.T.A.B. Oct. 16, 2019). In Snap, Inc. v.
`
`SRK Tech. LLC, the Board found this factor weighed in favor of not exercising
`
`discretion under § 314(a) given numerous differences in the art asserted “as well as
`
`the stay of the parallel District Court proceeding.” IPR2020-00820, Paper 15, at 16
`
`(P.T.A.B. Oct. 21, 2020) (emphasis added). In Sotera Wireless, Inc. v. Masimo
`
`Corp., the Board found this factor weighed in favor of not exercising discretion
`
`under § 314(a) in view of petitioner’s stipulation that “if IPR is instituted, [petitioner]
`
`will not pursue in the District Court Litigation any ground raised or that could have
`
`been reasonably raised in an IPR.” IPR2020-01019, Paper 12, at 18–19 (P.T.A.B.
`
`Dec. 1, 2020) (emphasis added). None of those unique facts exists here.
`
`Petitioner also misrepresents that this factor requires a complete identity of
`
`challenged claims between the two forums. Reply, at 2. That is not so. See POPR, at
`
`26–27; Samsung, IPR2020-01552, Paper 11, at 21–23. Moreover, Petitioner’s claim
`
`that Patent Owner may drop asserted claims at the district court before trial (Reply,
`
`at 2) is not only speculative but immaterial given the facts here. Petitioner’s
`4
`
`
`
`challenges in each ground of the instant Petition present the “same reasons” across
`
`all independent claims. Pet. at 15–39, 65–67. Thus, resolution of Petitioner’s
`
`challenge to any claim at the district court will resolve key issues in the Petition. See
`
`Fintiv, IPR2020-00019, Paper 11, at 13; Samsung, IPR2020-01552, Paper 11, at 23.
`
`Fintiv Factor 6: Other Relevant Considerations
`C.
`Petitioner’s (incorrect) characterization of the merits as “strong” (Reply, at 3)
`
`does not justify institution in view the required balancing of all the Fintiv factors,
`
`including the advanced stage of the parallel proceeding. Even an allegedly “strong
`
`case on the merits” can be outweighed by the facts underlying Fintiv factors 2–5
`
`collectively. Supercell Oy v. GREE, Inc., IPR2020-00215, Paper 10, at 18 (P.T.A.B.
`
`June 10, 2020); e.g., 10X Genomics, IPR2020-01180, Paper 23 at 16–17.
`
`And once again the cases cited by Petitioner are distinguishable. For example,
`
`in Apple Inc. v. Seven Networks, LLC, the Board instituted review largely because
`
`of the finding that “it would be inefficient to discretionarily deny institution” given
`
`the “unique circumstance … where the Office has already instituted proceedings
`
`challenging other patents in dispute in the parallel proceeding.” IPR2020-00235,
`
`Paper 10, at 17, 20 (P.T.A.B. July 28, 2020). There is no such “unique circumstance”
`
`here. Quite the opposite, the Board has denied institution on multiple other petitions
`
`filed by this same Petitioner against this same Patent Owner in view of similar
`
`circumstances in accordance with the Board’s discretion. See POPR, at 32.
`5
`
`
`
`II.
`
`The Petition Failed to Demonstrate that MH Was Publicly Accessible
`Petitioner’s contention that “particular evidence included with the petition”
`
`demonstrates that MH was publicly accessible, and thus a printed publication
`
`(Reply, at 6), is belied by Petitioner’s submission of multiple, new exhibits with its
`
`Reply. See Exs. 1022–1023. And, critically, while Petitioner received leave to file a
`
`reply to address the availability of MH as a prior art reference, Petitioner did not
`
`request leave, nor demonstrate the requisite “good cause,” to submit additional
`
`evidence regarding the same. See Hulu, LLC v. Sound View Innovations, LLC,
`
`IPR2018-01039, Paper 29, at 7 (P.T.A.B. Dec. 20, 2019); see also Guardian Alliance
`
`Techs., Inc. v. Miller, IPR2020-00031, Paper 27, at 8–9 (P.T.A.B. July 27, 2020)
`
`(noting the evidence presented “in the Petition” must “make a prima facie case of
`
`public accessibility” (emphasis added)). The Board should thus disregard new, and
`
`unauthorized, Exhibits 1022 and 1023. These exhibits should have been presented
`
`“in the Petition” to “make a prima facie case of public accessibility,” Guardian
`
`Alliance, IPR2020-00031, Paper 27, at 9, but undisputedly were not.
`
`The fact that Petitioner previously submitted these exhibits with a petition in
`
`a different proceeding (see Reply, at 7) only underscores Petitioner’s failure to
`
`submit these exhibits with the instant Petition. And Petitioner’s attempt to cast Patent
`
`Owner as somehow misrepresenting information to the Board regarding the public
`
`accessibly of MH in view of that different proceeding (Reply, at 7) is disingenuous
`6
`
`
`
`at best. “[T]he burden is on the petitioner to identify with particularity evidence
`
`sufficient to establish a reasonable likelihood that the reference was publicly
`
`accessible before the critical date of the challenged patent.” Hulu, IPR2018-01039,
`
`Paper 29, at 16. In its Preliminary Response, Patent Owner simply demonstrated that
`
`Petitioner had failed to carry its burden in the instant Petition. See POPR, at 45–55.
`
`In any event, Exhibits 1022 and 1023 fail to establish a reasonable likelihood
`
`that MH was “publicly accessible.” At most, the exhibits may demonstrate the MH
`
`was available on YouTube by 2014. But, as previously discussed (POPR, at 49–55),
`
`“[t]he availability of a reference on a website does not end the public accessibility
`
`inquiry.” Celltrion, LLC v. Biogen, Inc., IPR2017-01230, Paper 10, at 13 (P.T.A.B.
`
`Oct 12, 2017). Rather, Petitioner must show—with particularity—that MH was
`
`sufficiently indexed or catalogued on YouTube, or otherwise so independently well
`
`known to one with ordinary skill in the art, such that a skilled artisan, exercising
`
`reasonable diligence, could have located it. POPR, at 49, 55. But Petitioner has failed
`
`to do so. POPR, at 53–55. Petitioner’s expert’s vague and conclusory testimony that
`
`a POSITA would simply have known to use unspecified “indexing and search
`
`functions” of YouTube to find MH is insufficient. Cf. Google LLC v. IPA Techs.
`
`Inc., IPR2018-00384, Paper 8, at 13–15 (P.T.A.B. July 3, 2018) (requiring “evidence
`
`that a query of a search engine before the critical date … would have led to the
`
`reference appearing in the search results”).
`7
`
`
`
`Dated: March 5, 2021
`
`
`
`By: /John C. Alemanni/
`
`John C. Alemanni
`Reg. No. 47,384
`Lead Counsel for Patent Owner
`
`8
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that a copy of the foregoing Patent Owner’s
`
`Sur-Reply to Petitioner’s Reply to Patent Owner’s Preliminary Response has been
`
`served electronically via email upon counsel for Petitioner at bhoffman-
`
`PTAB@fenwick.com.
`
`Dated: March 5, 2021
`
`By: /John C. Alemanni/
`John C. Alemanni
`Reg. No. 47,384
`Lead Counsel for Patent Owner
`
`9
`
`